ReviewCurrent medical imaging2026
Hepatic Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma: A Diagnostic Imaging Challenge - A Focused Review and Case Report.
Review in Current medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma (EBV+ IFDCS) is a rare low-grade malignant neoplasm. Preoperative diagnosis of EBV+ IFDCS is challenging because it lacks specific clinical or laboratory manifestations as well as distinctive imaging features. This report presents a case of hepatic EBV+ IFDCS and reviews the relevant literature. The study summarized the imaging characteristics of this condition and provided insights to support preoperative imaging evaluation. CASE PRESENTATION: A 54-year-old asymptomatic woman was found to have a hepatic mass during a routine health screening and subsequently underwent surgical resection. Preoperative computed tomography and magnetic resonance imaging identified a lesion in the left hepatic lobe. The mass demonstrated marked but heterogeneous enhancement in the arterial phase, followed by decreased enhancement in the portal venous and delayed phases. The diagnosis of hepatic EBV+ IFDCS was confirmed by histopathological examination.
conclusionBecause the imaging findings of hepatic EBV+ IFDCS are variable, preoperative diagnosis remains challenging. This report aims to improve recognition of the imaging characteristics of this disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.